Logo
Position papers
Available in
English
BEUC's comments on the European Commission's proposal regulation Health Technology Assessment (HTAs)
Press releases
Available in
English
Today, the EU Commission has proposed to reinforce Member States’ collaboration when they assess the added value of health technologies, such as medicines, medical devices or surgeries. This will lead to a better use of taxpayers’ money, in turn channelling money towards more innovative treatments and research. BEUC supports the idea of joining efforts to conduct Health Technology Assessment (HTA) in Europe and highlights some requirements to make the system work for consumers.
Position papers
Available in
English
BEUC's response to the European Commission's public consultation on Transformation of Health and Care in the Digital Single Market.
Press releases
Available in
English
The European Commission opened a formal investigation into Aspen Pharma's pricing practices for cancer medicines. BEUC had requested the European Commission in 2016 to investigate the company’s significant price increases for some of its anticancer medicines.
Press releases
The European Consumer Organisation (BEUC) undertook a consumer performance check of the first two-and-a-half years of the Juncker Commission.1 We looked at the Commission’s legislative initiatives and its key policy actions and graded their performance on a scale from very good to very bad.